American Association for Cancer Research (AACR) Annual Meeting II, Virtual – June 22-24, 2020
Archives: Presentations
Presentations
Agonistic Death Receptor 5 (DR5) IgM antibody IGM-8444 induces tumor cell apoptosis in vitro and in vivo and has a favorable in vitro safety profile
American Association for Cancer Research (AACR) Annual Meeting II, Virtual – June 22–24, 2020 – Session: Antibody Technologies – Experimental and Molecular Therapeutics
A bispecific IgM antibody format for enhanced T cell dependent killing with minimal cytokine release
American Association for Cancer Research (AACR) Annual Meeting II, Virtual – June 22–24, 2020 – Session: Therapeutics Antibodies 4 – Immunology
High Avidity IgM-based CD20xCD3 Bispecific Antibody for Enhanced T-Cell Dependent Killing with Minimal Cytokine Release
American Society of Hematology (ASH) Annual Meeting – December 7-10, 2019
Agonist and Bispecific IgM: Nature’s Approach to Highly Avid, Multivalent Antibodies
PEGS Europe – November, 2019